Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who died.
Yoshida N, Sugiyama G, Sugi S, Satake K, Wakasugi D, Yamasaki S, Mihara Y, Matsuda K, Ida H, Ohshima K, Yamaguchi R, Nakashima M. Yoshida N, et al. Among authors: satake k. Mod Rheumatol Case Rep. 2020 Jul;4(2):161-167. doi: 10.1080/24725625.2019.1702493. Epub 2019 Dec 31. Mod Rheumatol Case Rep. 2020. PMID: 33087004
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V; OCEANIC-AF Steering Committee and Investigators. Piccini JP, et al. N Engl J Med. 2025 Jan 2;392(1):23-32. doi: 10.1056/NEJMoa2407105. Epub 2024 Sep 1. N Engl J Med. 2025. PMID: 39225267 Clinical Trial.
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors.
Yamamoto N, Koyama T, Sato J, Yoshida T, Sudo K, Iwasa S, Kondo S, Yonemori K, Kawasaki A, Satake K, Shibata S, Shimizu T. Yamamoto N, et al. Among authors: satake k. Cancer Chemother Pharmacol. 2024 Sep;94(3):491. doi: 10.1007/s00280-024-04645-9. Cancer Chemother Pharmacol. 2024. PMID: 38556530 Free PMC article. No abstract available.
Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors.
Yamamoto N, Koyama T, Sato J, Yoshida T, Sudo K, Iwasa S, Kondo S, Yonemori K, Kawasaki A, Satake K, Shibata S, Shimizu T. Yamamoto N, et al. Among authors: satake k. Cancer Chemother Pharmacol. 2024 Jul;94(1):109-115. doi: 10.1007/s00280-023-04627-3. Epub 2024 Jan 11. Cancer Chemother Pharmacol. 2024. PMID: 38206370 Free PMC article. Clinical Trial.
Lateral Lumbar Interbody Fusion within Three-level for Patients with Neurological Symptoms due to Vertebral Fragility Fractures in the Lumbar Spine.
Nagashima Y, Nishimura Y, Kanemura T, Hata N, Satake K, Akahori S, Ishii M, Tanei T, Takayasu M, Saito R. Nagashima Y, et al. Among authors: satake k. Neurol Med Chir (Tokyo). 2023 Dec 15;63(12):548-554. doi: 10.2176/jns-nmc.2023-0064. Epub 2023 Oct 18. Neurol Med Chir (Tokyo). 2023. PMID: 37853614 Free PMC article.
445 results